Aldeyra Therapeutics, Inc. (ALDX)
NASDAQ: ALDX · Real-Time Price · USD
1.780
+0.230 (14.84%)
At close: May 26, 2026, 4:00 PM EDT
1.750
-0.030 (-1.71%)
After-hours: May 26, 2026, 7:13 PM EDT
Aldeyra Therapeutics Market Cap
Aldeyra Therapeutics has a market cap or net worth of $107.37 million as of May 26, 2026. Its market cap has decreased by -16.77% in one year.
Market Cap
107.37M
Enterprise Value
57.88M
1-Year Change
-16.77%
Ranking
Category
Stock Price
$1.78
Market Cap Chart
Since May 2, 2014, Aldeyra Therapeutics's market cap has increased from $37.20M to $107.37M, an increase of 188.63%. That is a compound annual growth rate of 9.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 93.50M | -69.99% |
| Dec 31, 2025 | 311.60M | 4.85% |
| Dec 31, 2024 | 297.20M | 43.92% |
| Dec 29, 2023 | 206.50M | -49.34% |
| Dec 30, 2022 | 407.60M | 75.39% |
| Dec 31, 2021 | 232.40M | -12.73% |
| Dec 31, 2020 | 266.30M | 63.98% |
| Dec 31, 2019 | 162.40M | -25.44% |
| Dec 31, 2018 | 217.80M | 67.54% |
| Dec 29, 2017 | 130.00M | 93.16% |
| Dec 30, 2016 | 67.30M | 2.12% |
| Dec 31, 2015 | 65.90M | 63.93% |
| Dec 31, 2014 | 40.20M | 8.06% |
| May 2, 2014 | 37.20M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Q32 Bio | 98.35M |
| LeonaBio | 97.04M |
| Rein Therapeutics | 95.83M |
| PolyPid | 95.80M |
| Annovis Bio | 94.87M |
| Oncolytics Biotech | 94.01M |
| Anixa Biosciences | 93.54M |
| Edesa Biotech | 92.94M |